-VISIT OUR OTHER FORUMS- OB-GYN-L Ultrasound Ultrasound History Fibroid Forum Physicians-in-Training Tech Talk OBSTET-L (portuguese) OBGIN-L (spanish) Nursing

Re: Is anyone concerned about health and liability risk involving infused ibandronate... From: art fougner, md (evsono@pipeline.com) Sat May 30 08:06:14 2009 Messages sorted by: [ date ][ thread ][ subject ][ author ] Next message: emilio porro: "How softening uterine cervix and pelvic tissue for an easier birth" Previous message: Annette Keen: "Is anyone concerned about health and liability risk involving infused ibandronate..." In reply to: Annette Keen: "Is anyone concerned about health and liability risk involving infused ibandronate..." And you are ... ? At Sat, 30 May 2009, Annette Keen wrote: > >which is being heavily advertised and marketed. There are reports that >Merck's research on bisphosphanates in general may have lacked peer >review the company implied. > >-- >A. Keen > -- art fougner, md "May The Wings of Liberty Never Lose a Feather." - Jack Burton Next message: emilio porro: "How softening uterine cervix and pelvic tissue for an easier birth" Previous message: Annette Keen: "Is anyone concerned about health and liability risk involving infused ibandronate..." In reply to: Annette Keen: "Is anyone concerned about health and liability risk involving infused ibandronate..."

Return to

Mail a New Message to the Forum: ob-gyn-l@obgyn.net Forum Administrator: geffrey.klein@obgyn.net Report Technical Problems: webmaster@obgyn.net Last Updated: Mon Nov 2 05:14:37 2009

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.